Search results - ORA - Oxford University Research Archive

1 - 19 of 19

1

Journal article

Impact of detecting potentially serious incidental findings during multi-modal imaging

Gibson, L, Littlejohns, T, Adamska, L, et al.
2017-11-30

2

Journal article

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Clemens, SAC, Folegatti, PM, Emary, KRW, et al.
2021-10-06

3

Journal article

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial

Qadri, F, Khanam, F, Liu, X, et al.
2021-08-09

4

Journal article

Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent pneumococcal conjugate vaccine in the United Kingdom

Kandasamy, R, Voysey, M, Collins, S, et al.
2019-04-22

5

Journal article

Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal

Colin-Jones, R, Shakya, M, Voysey, M, et al.
2019-03-07

6

Journal article

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Feng, S, Phillips, DJ, White, T, et al.
2021-09-29

7

Journal article

Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine

Aguas, R, Bharath, A, White, LJ, et al.
2021-11-04

8

Journal article

The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis

Oguti, B, Ali, A, Andrews, N, et al.
2021-12-21

9

Journal article

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy

Pace, D, Khatami, A, Attard-Montalto, S, et al.
2016-10-28

10

Journal article

Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402].

Iro, M, Snape, M, Voysey, M, et al.
2017-05-05

11

Journal article

The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis

Voysey, M, Kelly, D, Fanshawe, T, et al.
2017-05-15

12

Journal article

Childhood invasive bacterial disease in Kathmandu, Nepal (2005-2013)

Carter, MJ, Gurung, M, Pokhrel, B, et al.
2021-12-21

13

Journal article

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial.

Iro, M, Snape, M, Voysey, M, et al.
2016-11-01

14

Journal article

Differences in immunization site pain in toddlers vaccinated with either the 10- or the 13-valent pneumococcal conjugate vaccine

Trück, J, Kelly, S, Jawad, S, et al.
2018-01-10

15

Journal article

The design and analysis of seroefficacy studies for typhoid conjugate vaccines

Liu, X, Pitzer, V, Pollard, A, et al.
2019-03-07

16

Journal article

AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire.

Swanson, PA, Padilla, M, Hoyland, W, et al.
2021-09-30

17

Journal article

Antibody persistence and booster responses to Split-Virion H5N1 avian Influenza vaccine in young and elderly adults

Lazarus, R, Kelly, S, Snape, M, et al.
2016-11-04

18

Journal article

A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data

Phillips, MT, Meiring, JE, Voysey, M, et al.
2021-08-24

19

Journal article

Persistence of immunity following 2-dose priming with a 10-valent pneumococcal conjugate vaccine at 6 and 10 weeks or 6 and 14 weeks of age in Nepalese toddlers

Gurung, M, Bijukchhe, SM, Hariri, P, et al.
2021-07-20

TO TOP